Surgery Partners, Inc. (NASDAQ: SGRY) Investor Investigation over potential Wrongdoing
An investigation on behalf of investors in Surgery Partners, Inc. (NASDAQ: SGRY) shares over potential wrongdoing.
Investors who purchased shares of Surgery Partners, Inc. (NASDAQ: SGRY) have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Surgery Partners, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
Surgery Partners, Inc. reported that its annual Total Revenue rose from over $1.34 billion in 2017 to over $1.77 billion in 2018 and that its Net Loss increased from $52.98 million in 2017 to $205.7 million in 2018.
Shares of Surgery Partners, Inc. (NASDAQ: SGRY) closed on January 24, 2020, at $18.07 per share.
Those who purchased shares of Surgery Partners, Inc. (NASDAQ: SGRY) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North
San Diego, CA 92108
E-Mail: [email protected]
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Surgery Partners, Inc. (NASDAQ: SGRY) Investor Investigation over potential Wrongdoing here
News-ID: 2032114 • Views: 388
More Releases from Shareholders Foundation
Aytu BioScience, Inc. (NASDAQ: AYTU) Investor Investigation over possible Securi …
An investigation was announced concerning potential securities laws violations by Aytu BioScience, Inc. in connection with certain financial statements. Investors who purchased shares of Aytu BioScience, Inc. (NASDAQ: AYTU), have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Aytu BioScience, Inc. (NASDAQ: AYTU regarding its business, its prospects and its
Zuora, Inc. (NYSE: ZUO) Long Term Investor Alert: Investigation over concerning …
An investigation was announced over potential breaches of fiduciary duties by certain directors of Zuora, Inc.. Investors who are current long term investors in Zuora, Inc. (NYSE: ZUO) shares, have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554. The investigation by a law firm for investors in NYSE: ZUO stocks follows a lawsuit filed against Zuora, Inc. over alleged securities laws violations. The
Lawsuit filed for Investors in shares of Phoenix Tree Holdings Limited (NYSE: DN …
An investor, who purchased shares of Phoenix Tree Holdings Limited (NYSE: DNK), filed a lawsuit over alleged Securities Laws violations by Phoenix Tree Holdings Limited in connection with the Company's January 22, 2020 initial public offering ("IPO"). purchased shares of Phoenix Tree Holdings Limited (NYSE: DNK), you have certain options and for certain investors are short and strict deadlines running. Deadline: June 26, 2020. NYSE: DNK investors should contact the Shareholders
Deadline on May 18th upcoming in Lawsuit for Investors in LogicBio Therapeutics, …
A deadline is coming up on May 18, 2020 in the lawsuit filed for certain investors of LogicBio Therapeutics, Inc. (NASDAQ: LOGC) over alleged securities laws violations by LogicBio Therapeutics, Inc. Investors who purchased shares of LogicBio Therapeutics, Inc. (NASDAQ: LOGC) have certain options and there are strict and short deadlines running. Deadline: May 18, 2020. NASDAQ: LOGC stockholders should contact the Shareholders Foundation at [email protected] or call +1(858) 779 -
More Releases for Surgery
5th International Surgery and Surgeons Meet will be organized on June 26-27,2019 in New York, USA. The conference highlights the theme “Disseminating advance research and Innovative Technology in the field of Surgery”. Surgeons Meet 2019 aims to gather leading surgeons, eminent scientists, research scholars, students along with industrial and pharmacy professionals to express their views on the latest technologies for future Surgery research. The event is designed in a way
Eyelid Surgery in Bangalore
Blepharoplasty or Eye Surgery is the surgical treatment to correct either of droopy eyelids or puffy under eye areas. If we talk of the specifics which eye surgery or blepharoplasty can help us with, the uses would be the following: ● Contouring and tightening the sagging skin, usually of the upper eyelid ● Removal of the fatty deposits in the under eye region which result in puffiness ● Eye bags which are there but devoid of
Surgery Conference 2018
After the successful conference of Surgical Nursing and Nursing Education 2017, Conference Series Ltd is bringing forward another conference on 28th Surgical Nursing and Nurse Education Conference (Surgical Nursing 2018) which is scheduled on August 08-09, 2018 at Osaka, Japan with a theme of “Innovative Innovations towards Surgical Nursing and Nurse Education”. The conference invites all the participants across the globe to attend and share their insights and convey recent
The Hospital undergoing surgery
Gustavo Frickle Hospital is a new 92,000 sqm building in Vi?a del mar, Chile. This modern 11-storey structure with 554 rooms, clinical wards and an heliport, will be inaugurated in March 2017. Providing patients and medical personnel with ideal temperature and humidity conditions as well as huge amount of sanitary hot water, achieving these with reduced acoustic emissions and highest efficiency, are the key challenges for the HVAC system of the
ESMR over surgery
ESMR - A world class treatment for the first time in India, a breakthrough in management of Refractory Angina Pectoris with end-stage coronary Artery Disease not Suitable for Revascularization.ESMR therapy is a new non invasive therapy approach using Extracorporeal Shockwave technology for Myocardial Revascularization.ESMR in india,Non invasive Cardiac Angiogenesis therapy,Non invasive bypass treatment,ESMR therapy.Chennai hospital introduces one more life saver in cardiac treatments first of its kind in india,Extra Corporeal
Hande hospital was started in 1984 by Dr. H. V. Hande, former Health Minister, Govt of Tamilnadu. Dr.Hande has been (and continues to be) in practice for the past 52 years in India at Chennai. Hande Hospital at chennai in india has recently been expanded into a 50 bed hospital performing laproscopic, cosmetic surgery and master health checkup, being run by Dr. H.Krishna Hande MS.,FRCS.,MCH (Plastic) FMMC. Who